Crawford & Company Reports 2017 Fourth Quarter Results
Mar 07, 2018 21:15 pm UTC| Business
ANNOUNCES NEW GLOBAL SERVICE LINE STRUCTURE ISSUES INITIAL 2018 GUIDANCE ATLANTA, March 07, 2018 -- Crawford Company (www.crawfordandcompany.com) (NYSE:CRD-A)(NYSE:CRD-B), the world’s largest publicly listed...
B. Riley Financial Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 07, 2018 21:14 pm UTC| Business
Revenue of $110.2 Million in Q4 and $322.2 Million for 2017Adjusted EBITDA of $21.4 Million in Q4 and $69.8 Million for 2017Capital Markets Revenue Up 33% over Q3 2017Valuation and Appraisal Segment Record Revenues of...
Mar 07, 2018 21:09 pm UTC| Business
VANCOUVER, British Columbia, March 07, 2018 -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) (“Intrinsyc” or the “Company”), a leading provider of solutions for the development of intelligent connected...
KCAP Financial, Inc. Announces Full Year 2017 Financial Results
Mar 07, 2018 21:07 pm UTC| Business
NEW YORK, March 07, 2018 -- KCAP Financial, Inc. (Nasdaq:KCAP) (“KCAP” or the “Company”) announces its full year 2017 financial results.Financial Highlights Net investment income for the year ended December 31, 2017...
ZAGG Reports Record 2017 Fourth Quarter and Full Year Results
Mar 07, 2018 21:07 pm UTC| Business
SALT LAKE CITY, March 07, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, today announced financial results for the fourth quarter and twelve months ended December 31, 2017. Fourth Quarter...
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 07, 2018 21:06 pm UTC| Business
BURLINGAME, Calif., March 07, 2018 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that...
AIT Therapeutics to Present at Two Investor Conferences
Mar 07, 2018 21:06 pm UTC| Business
REHOVOT, Israel and NEW YORK, March 07, 2018 -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious...